ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of
medical devices and related software solutions, announced today
that it has received 510(k) clearance from the U.S. Food and Drug
Administration to market and begin U.S. distribution of the new
ZOLL X Series™ Monitor/Defibrillator. Designed primarily for
EMS operations, the X Series is about half the size and half the
weight of competitive full-featured monitor/defibrillators, yet
much more powerful and built to the most extensive standards for
ruggedness.
ZOLL X Series Monitor/Defibrillator
Granted 510(k) Clearance by U.S. Food and Drug Administration
(Photo: Business Wire)
Weighing less than 12 pounds (6 kilograms), the X Series is
compact without compromise in capability, performance, or display
size. This monitor/defibrillator combines the clinically superior
therapeutic capabilities of ZOLL defibrillation, pacing, and CPR
assistance with advanced monitoring parameters.
“We believe the X Series is a game changer for ZOLL in the EMS
market. We have the size and weight advantages that ZOLL is known
for without compromising features or functionality,” said Jonathan
A. Rennert, President of ZOLL. “The X Series has every advanced
monitoring and communication capability required by EMS providers
and, ultimately, critical care transport operations.”
“The X Series should be a ‘must see’ for any service interested
in cutting edge technology. It was built on the Propaq® MD
Monitor/Defibrillator platform, which in little more than a year
has become a standard of care for air medical operations
worldwide,” he added.
The large bright screen on the X Series allows for simultaneous
viewing of up to four different waveform traces, as well as
split-screen 12-lead views. The device incorporates Masimo rainbow®
SET CO-Oximetry™ technology, which provides Masimo SET® SpO2, pulse
rate, perfusion index (PI), carboxyhemoglobin (SpCO®), and
methemoglin (SpMet®). Welch Allyn Non-invasive Blood Pressure
(NIBP) technology—Sure BP® and Smart Cuf®—is yet another capability
that sets the X Series apart from other defibrillators.
Acknowledged as the best of class NIBP technology, it offers
faster, more accurate readings.
For unequaled CPR support, the X Series features ZOLL’s full
suite of CPR assist tools including Real CPR Help® for real-time
CPR feedback and See-ThruCPR® artifact filtering to help minimize
the length of pauses. It’s the first device to feature ZOLL’s CPR
Dashboard™, which displays CPR quality measures in real time.
A major breakthrough in the X Series is its advanced
communications capabilities. Leveraging a dedicated onboard data
processor—essentially a smart phone in the box—the X Series is the
first and only EMS monitor/defibrillator that can communicate via
Bluetooth, WiFi, or USB cellular modem. Streaming data can be sent
to hospitals or clinicians at remote locations while rescuers are
caring for patients. For STEMI patients, the X Series is designed
to speed door-to-balloon times with quick and accurate 12-lead
acquisition, interpretation, and transmission. The X Series fully
integrates with ZOLL’s RescueNet® 12-Lead and RescueNet Medgate
Management Systems.
The X Series, along with the Propaq MD, are the only two
defibrillators to earn an IP55 ingress protection rating for dust
and water. Both units are virtually immune to a three-minute,
high-pressure onslaught of water and meet the most stringent
specifications for shock and vibration. The X Series is powered by
a SurePower™ II high-capacity lithium-ion battery for six hours of
continuous run time.
About ZOLL Medical Corporation
ZOLL Medical Corporation develops and markets medical devices
and software solutions that help advance emergency care and save
lives, while increasing clinical and operational efficiencies. With
products for defibrillation and monitoring, circulation and CPR
feedback, data management, fluid resuscitation, and therapeutic
temperature management, ZOLL provides a comprehensive set of
technologies that help clinicians, EMS and fire professionals, and
lay rescuers treat victims needing resuscitation and critical
care.
A NASDAQ Global Select company and a three-time Forbes 100 Most
Trustworthy Company, ZOLL was designated in 2011 as one of Forbes
Top 100 Small Public Companies in America with annual revenues
under $1 billion. ZOLL develops and manufactures its products in
the United States, in California, Colorado, Illinois,
Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct
sales and service representatives, 1,100 business partners, and 200
independent representatives serve our customers in over 140
countries around the globe. For more information, visit
www.zoll.com.
Certain statements contained in this press release, including
statements regarding the anticipated development of the Company's
business, and other statements contained herein regarding
matters that are not historical facts, are “forward-looking”
statements (as defined in the Private Securities Litigation Reform
Act of 1995). Because such statements are subject to risks and
uncertainties, actual results may differ materially from those
expressed or implied by such forward-looking statements. Factors
that could cause actual results to differ materially from those
expressed or implied by such forward-looking statements include,
but are not limited to, those factors discussed in the section
entitled “Risk Factors” in the Company's Annual Report on Form 10-K
filed with the SEC on November 23, 2011, as updated by the
Company’s subsequent SEC filings, including Quarterly Reports on
Form 10-Q. You should not place undue reliance on the
forward-looking statements in this press release, and the Company
disavows any obligation to update or supplement those statements in
the event of any changes in the facts, circumstances, or
expectations that underlie those statements.
Copyright © 2012 ZOLL Medical Corporation. All rights reserved.
CPR Dashboard, Real CPR Help, RescueNet, See-Thru CPR, SurePower, X
Series and ZOLL are trademarks and/or registered trademarks of ZOLL
Medical Corporation in the United States and/or other countries.
Masimo, SpCO, SpMet, Rainbow, and SET are registered trademarks of
Masimo Corporation. All trademarks are the property of their
respective owners.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50215312&lang=en
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Zoll (NASDAQ:ZOLL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024